Centre for Global Health Policy

Antimicrobial Resistance

Members of the Centre for Global Health Policy engage in a number of different activities on antimicrobial resistance, these include:

Reports 

 

'Strategies for achieving global collective action on antimicrobial resistance' bulletin

Director of the Centre for Global Health Policy, Professor Stefan Elbe, co-authored "Strategies for achieving global collective action on antimicrobial resistance", Bulletin of the World Health Organization. Read this here.

 

 'Antimicrobial Resistance and International Relations' research brief

Director of the Centre for Global Health Policy, Professor Stefan Elbe, co-authored 'Antimicrobial Resistance and International Relations' research brief. Read this here.

 

'Antomicrobial resistance in humans and animals in low and middle income countries: How knowledge and action can be strengthened at a national level' report

Read this Wilton Park report authored by the Centre for Global Health Policy here.

 

'Antimicrobial resistance: Building national reponses in low and middle income countries' report

Read this Wilton Park report authored by the Centre for Global Health Policy here.

 

 

Events

 

Pharmaceuticals and global health: Medicines, markets, manufacturers, and medical countermeasures

Pharmaceuticals are pivotal to global health policy. Outbreaks of pandemic flu, Ebola, MERS and now Zika are intensifying international efforts to streamline pharmaceutical development. Concern about global health security threats – from the rise of anti-microbial resistance to the spectre of a bio-terrorist attack – are fanning bespoke pharmaceutical regimes for the development, manufacture and distribution of innovative medical countermeasures. This workshop brought together a number of predominantly UK-based researchers analysing different dimensions of the role played by pharmaceuticals in contemporary global health policy – from medicines and medical countermeasures, through to markets and manufacturers. Read the Pharmaceuticals and Global Health Report [PDF 387.96KB]. Read our Workshop Summary [PDF 363.57KB]. To learn more about this workshop, see here.

 

The emerging global crisis on antimicrobial resistance: Towards an agenda for international relations' workshop

While a small number of IR scholars have begun to examine the AMR issue, the discipline has not to date systematically engaged with it. This workshop aimed to stimulate such engagement, mapping the (potential) contours of IR’s engagement with the AMR issue and stimulating further research from the IR field. Read the workshop summary here. Read about this event here.

 

Networks 

 

The Sussex Antimicrobial Resistance Study Group

The composition of the Sussex AMR study group reflects the complexity of the AMR global challenge and the required capabilities to address this, by bringing together researchers from across the social and natural sciences. This multi-disciplinary group involves researchers from the Centre for Global Health Policy, the Institute of Development Studies, the Science Policy Research Unit (SPRU), the Wellcome Trust Brighton and Sussex Centre for Global Health Research at the Brighton and Sussex Medical School and the Social, Technological and Environmental Pathways to Sustainability (STEPS) Centre. The AMR study group serves as a platform to generate transformative knowledge through interdisciplinary collaborations. We hold regular meetings to share research expertise, engage in new ways of thinking about critical issues, and to develop partnerships, projects, and publications aimed a range of audiences, in order to contribute to addressing the challenge of AMR. Visit the website here.

If you are working in the area of anti-microbial resistance, we'd be interested to hear from you. Our contact details are available here.